Detectnet Prices, Coupons and Patient Assistance Programs
Detectnet (copper Cu 64 dotatate) is a member of the diagnostic radiopharmaceuticals drug class and is commonly used for Positron Emission Tomography Imaging.
The cost for Detectnet intravenous solution (37 MBq/mL) is around $957 for a supply of 1 solution, depending on the pharmacy you visit. Prices are for cash paying customers only and are not valid with insurance plans.
This Detectnet price guide is based on using the Drugs.com discount card which is accepted at most U.S. pharmacies.
Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.
Drugs.com Printable Discount Card
The free Drugs.com Discount Card works like a coupon and can save you up to 80% or more off the cost of prescription medicines, over-the-counter drugs and pet prescriptions.Print Free Discount Card
Please note: This is a drug discount program, not an insurance plan. Valid at all major chains including Walgreens, CVS Pharmacy, Target, WalMart Pharmacy, Duane Reade and 65,000 pharmacies nationwide.
Detectnet Coupons and Rebates
Detectnet offers may be in the form of a printable coupon, rebate, savings card, trial offer, or free samples. Some offers may be printed right from a website, others require registration, completing a questionnaire, or obtaining a sample from the doctor's office.
There are currently no Manufacturer Promotions that we know about for this drug.
Patient Assistance Programs for Detectnet
Patient assistance programs (PAPs) are usually sponsored by pharmaceutical companies and provide free or discounted medicines to low income or uninsured and under-insured people who meet specific guidelines. Eligibility requirements vary for each program.
There are currently no Patient Assistance Programs that we know about for this drug.
More about Detectnet (copper Cu 64 dotatate)
- Side effects
- Drug interactions
- Dosage information
- Drug class: diagnostic radiopharmaceuticals
- FDA approval history